Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Eribulin in advanced breast cancer: safety, efficacy and new perspectives.
Future Oncol. 2017 Dec;13(30):2759-2769. doi: 10.2217/fon-2017-0283. Epub 2017 Sep 13.
Future Oncol. 2017.
PMID: 29219017
Review.
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.
Lo Nigro C, Ricci V, Vivenza D, Granetto C, Fabozzi T, Miraglio E, Merlano MC.
Lo Nigro C, et al. Among authors: miraglio e.
World J Gastroenterol. 2016 Aug 14;22(30):6944-54. doi: 10.3748/wjg.v22.i30.6944.
World J Gastroenterol. 2016.
PMID: 27570430
Free PMC article.
Review.
Item in Clipboard
A prospective randomised study of transvaginal ultrasound effects of tamoxifen and exemestane in postmenopausal women with early breast cancer.
Garrone O, Bertelli G, Principe E, Lewis PD, Occelli M, Miraglio E, Merlano MC.
Garrone O, et al. Among authors: miraglio e.
Tumori. 2014 Nov-Dec;100(6):620-4. doi: 10.1700/1778.19264.
Tumori. 2014.
PMID: 25688495
Clinical Trial.
Item in Clipboard
Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients.
Lo Nigro C, Ricci V, Vivenza D, Monteverde M, Strola G, Lucio F, Tonissi F, Miraglio E, Granetto C, Fortunato M, Merlano MC.
Lo Nigro C, et al. Among authors: miraglio e.
World J Gastrointest Oncol. 2016 Feb 15;8(2):222-30. doi: 10.4251/wjgo.v8.i2.222.
World J Gastrointest Oncol. 2016.
PMID: 26909137
Free PMC article.
Item in Clipboard
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Marmorino F, Salvatore L, Barbara C, Allegrini G, Antonuzzo L, Masi G, Loupakis F, Borelli B, Chiara S, Banzi MC, Miraglio E, Amoroso D, Dargenio F, Bonetti A, Martignetti A, Paris M, Tomcikova D, Boni L, Falcone A, Cremolini C.
Marmorino F, et al. Among authors: miraglio e.
Br J Cancer. 2017 Jan;116(3):318-323. doi: 10.1038/bjc.2016.413. Epub 2017 Jan 12.
Br J Cancer. 2017.
PMID: 28081548
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study.
Cazzaniga ME, Airoldi M, Arcangeli V, Artale S, Atzori F, Ballerio A, Bianchi GV, Blasi L, Campidoglio S, Ciccarese M, Cursano MC, Piezzo M, Fabi A, Ferrari L, Ferzi A, Ficorella C, Frassoldati A, Fumagalli A, Garrone O, Gebbia V, Generali D, La Verde N, Maur M, Michelotti A, Moretti G, Musolino A, Palumbo R, Pistelli M, Porpiglia M, Sartori D, Scavelli C, Schirone A, Turletti A, Valerio MR, Vici P, Zambelli A, Clivio L, Torri V; on behalf of; EVA Study Group.
Cazzaniga ME, et al.
Breast. 2017 Oct;35:115-121. doi: 10.1016/j.breast.2017.06.043. Epub 2017 Jul 13.
Breast. 2017.
PMID: 28711793
Item in Clipboard
Cite
Cite